Randomized, Prospective, Double-Blind Trial of PPI vs Placebo in Prevention of Gastrojejunal Strictures After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastric disorders
- Focus Pharmacodynamics
- 18 May 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 25 Feb 2009 New trial record